Death due to treatment of Covid-19 with anti-helminth drugs

AmericaThe New Mexico state government recorded two deaths suspected of taking ivermectin – an unlicensed drug in the treatment of Covid-19.

In a report on the Covid-19 situation, on September 22, the head of the New Mexico State Department of Health, Dr. David Scrase, said that two people had died, suspected of being ivermectin poisoning. One of them has a severe Covid-19 infection.

“This is a serious issue to watch out for,” said Scrase.

On August 21, the US Food and Drug Administration (FDA) advised people not to use ivermectin, an anti-parasitic drug on pets to treat Covid-19. The FDA warns that ivermectin is “not an antiviral drug,” and that taking it in large doses is dangerous and can cause serious health damage. The drug, commonly used in animals, has been approved for the treatment of parasitic worms in humans, but only in small doses.

In a medical advisory published on August 26, the US Centers for Disease Control and Prevention (CDC) said that use of ivermectin can cause “gastrointestinal symptoms such as nausea, vomiting Vomiting and diarrhea, overdose can lead to hypotension and neurological effects such as decreased consciousness, loss of consciousness, hallucinations, convulsions, coma and death.

In addition, the New Mexico Department of Health warned that invermectin could interact with a user’s other medications, leading to symptoms such as vomiting, diarrhea, a drop in blood pressure and other side effects.

The FDA has not approved the use of invermectin in the treatment of Covid-19. However, many people are in favor of the drug, especially those who are skeptical about vaccines, treatments or public health measures such as wearing masks.

Mr. Scrase has expressed concern about pseudoscientific messages about invermectin. Last week, the state’s Poison Control Center reported that the number of calls related to ivermectin had tripled compared with 2020.

A box of ivermectin dewormer at a pharmacy in Paris, France, April 2020. Photo: Reuters.

Mai Dung (Follow USA Today, CNN)


Leave a Reply

Your email address will not be published. Required fields are marked *